TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: HIV‐1 RNA less than 50 copies/ml by week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall probability of pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: method-failure probability of pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: incidence of breakthrough bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: MDD episode duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for one-on-one telephone counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall study program rating
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: non-medication-related interruptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adenoma miss-rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean resting oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: extent of skin involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: infant supine sleep position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correct car seat use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Request for analgesics
Endpoint domain: Adverse events/effects
Primary endpoint: change in height from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum PCT concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Measures of impairment (FMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of task performance (JTHFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Finger individuation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal running distance in a 12-minute test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative transfusion requirement
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of hearing impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of hearing impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: lesion progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: segment occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of follow-up care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mean absolute force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: max force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPI change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of neck and shoulders complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PC20 (bronchoconstricted at lowest methacholine concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete cytogenetic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal symptoms for itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal symptoms for burning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal lavage fluid 15-HETE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal respiratory distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Emergency caesareans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PV change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative bioavailability of sunitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean midazolam exposure (AUC(0‐24 h))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Perps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: self-reported social connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: recall of self-referent dementia-related information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Spasticity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Ankle Active Dorsiflexion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: tooth positions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent infection within one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intravascular hemolysis
Endpoint domain: Adverse events/effects
Primary endpoint: Survival analysis for contact lenses
Endpoint domain: Mortality/survival
Primary endpoint: Ovarian hyperstimulation syndrome incidence
Endpoint domain: Adverse events/effects
Primary endpoint: satisfaction with tape use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: muscle fatigue resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Magnitude error absolute value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Astigmatism vector error (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of facial appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety (absence of local infection, foreign-body reaction, and migration of the product)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in hospital costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Anterior movement ratio for soft to hard tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subnasal length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for detecting ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: late lumen loss at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved walking after DCB treatment at six months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: primary patency after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initiation of vaginal sex by ninth grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall birth experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional impact of NOH
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total label recovery at 120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of LUBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of LUBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean KI scores and hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved glycemic management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rSBA titers ≥128 one year after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain relief of 50% or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant functional improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Immunogenicity measured by 4-fold changes in serotype-specific immunoglobulin G titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe acute reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality (deaths during follow-up)
Endpoint domain: Mortality/survival
Primary endpoint: Serum melatonin (MT) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAB therapeutic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction of leaks/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved changes in urinary symptom interference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GI complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Apparent clearance (CLM/F) for DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution (V3/F) for DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score change from baseline to follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seizure worry change from baseline to follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive functioning change from baseline to follow-up
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hip pain during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short term pain response
Endpoint domain: Adverse events/effects
Primary endpoint: internal locus of control
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bioavailability of CsA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Bacteremias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Nosocomial infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quality of Life (QoL) improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental component of the SF-36
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Team grading reproducibility for FTMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer courses of oral steroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer periods of worsening symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day-to-day peak flow variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Occipitofrontal circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duodenal ulcer healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement in activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in HHT epistaxis severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of postoperative nausea
Endpoint domain: Adverse events/effects
Primary endpoint: EPCs number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of blood spot samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects obtaining testable blood spot specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct answers to HIV risk questions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NOD1 and NOD2 mRNA expression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial function preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Seropositivity for vaccine antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of hydration of the SC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: cumulative 1-year fall incidence
Endpoint domain: Mortality/survival
Primary endpoint: Increase in physical activity levels in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in childhood obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistent disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lean body mass (LBM) gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of upper respiratory tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: suppression of erosion progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: suppression of synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: suppression of osteitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NTproBNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary infection
Endpoint domain: Adverse events/effects
Primary endpoint: Volume of macrocystic and microcystic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial appearance satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of stooling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Infant's sleep improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: retinal reattachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: media clarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mood symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency and severity of firesetting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: family carer health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Circulating progenitor cells (CD34+/CD45–/dim)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mortality from any cause
Endpoint domain: Mortality/survival
Primary endpoint: shunt-related morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy and safety profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FVC percent predicted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fracture rate of ceramic inlays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction rate of ceramic and gold inlays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Procedural memory consolidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevations of bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: compensated hemolytic anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to transition from PCA to oral pain medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adductor muscle tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Range of motion in hip joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Independent walking, running and jumping abilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Likelihood of undergoing lobectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cell counts in sputum samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell viability in sputum samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophil cationic protein (ECP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regulation of uterine and endometrial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: length of hospitalization in ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: length of hospitalization in general ward
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: YMDD mutation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ALT recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: AST recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Prognostic indicator of postnatal outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working Memory Capacity (WMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abortion completeness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of patients taking a calcium supplement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fetal acidosis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal nausea incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal vomiting incidence
Endpoint domain: Adverse events/effects
Primary endpoint: days homeless
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in diagnosis due to AVSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function-5 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NNA reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attack-free patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OIH development after abrupt withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores in HPT and CPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Community participation sufficiency
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Child participation in DDR
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SAS-CA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-I responder rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment-emergent suicidality
Endpoint domain: Adverse events/effects
Primary endpoint: Genetic instability of microsatellite repeat sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: hallucination distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative peak latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving HbA1c levels <7.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: repeat-screening mammograms
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: clinical improvements across motor outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: International Knee Documentation Committee Score ratings
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Kujala patellofemoral score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Higher scores in simulated performance of basic NR skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shorter time to effective BMV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes